Letter urging the UK government to support transparency resolution at WHA
The April 29, 2019 version of the resolution, sent to governments by the WHO with ten co-sponsors from Europe, Asia and Africa, was focused on transparency, providing concrete measures to address high drug prices and aimed to help remedy the information asymmetry between governments and pharmaceutical companies when negotiating medicine prices.The resolution, set out an ambitious but practical agenda for making drug prices, research and development (R&D) investments, patent landscapes and clinical trial outcomes progressively more transparent, and access to information more equal.
We strongly oppose the proposals made by the UK Government and several countries to dilute this resolution.
This letter to the World Health Organisation delegates, signed by Global Justice Now and other UK-based organisations, urges the UK to act in the national public interest, withdraw its amendments and instead support an effective resolution that demands genuine transparency as a practical agenda for tackling high drug prices and the inefficiencies within the current R&D system.
